<DOC>
	<DOCNO>NCT02717221</DOCNO>
	<brief_summary>The investigator develop 18F-MPG targeted molecular imaging agent noninvasive repeatable detect EGFR-activating mutational status .</brief_summary>
	<brief_title>In Vivo EGFR Molecular Classification</brief_title>
	<detailed_description>The goal investigator evaluate use 18F-MPG novel PET/CT radiotracer monitor EGFR-activating mutational status identify EGFR-TKIs benefit NSCLC patient . investigator want evaluate use 18F-MPG lung cancer image adult NSCLC patient different EGFR mutational status primary metastatic cancer .</detailed_description>
	<criteria>Advanced NSCLC 18 year old A life expectancy least 12 week Presence malignant lesion within chest least 0.5 cm diameter measure compute tomography ( CT ) Written informed consent Claustrophobia Pregnancy Metal implant thorax</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>